← Leaderboards
Richard N Fine
State University New York Stony Brook
$2,120,761
Attributed
$2,120,761
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2005–08$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
Funding mix
By agency
NIH$8,373,065 · 2
By mechanism
M01$6,252,304 · 1
U01$2,120,761 · 1
Top collaborators
No co-investigators on record.
Most similar at State University New York Stony Brook
Same institution · by research overlap
- Ute M Moll$14,001,329
- Leon C Moore$1,160,827
- Scott McNeill Sieburth$1,797,607
- Dilya A Whyte$6,488
- Asif Younas$0
Others in their field
Top investigators on “Proteinuria”
- Sumant Singh Chugh · Rush University Medical Center$16,742,378
- Susan L Furth · Johns Hopkins University$14,867,927
- Bradley Alan Warady · Children'S Mercy Hosp (Kansas City, Mo)$14,607,267
- Andrzej S Krolewski · Joslin Diabetes Center$12,693,842
- Martin R. Pollak · Beth Israel Deaconess Medical Center$12,517,502
- Stuart Johnston Knechtle · University Of Wisconsin Madison$11,789,092
Research focus
ProteinuriaCorticosteroid AnalogGlomerulosclerosisDrug Adverse EffectProteomicsSirolimusPathologic ProcessChronic Renal FailurePatient Oriented ResearchClinical ResearchMethylprednisoloneClinical TrialsImmunotherapyCombination ChemotherapyImmunosuppressiveKidney Disorder ChemotherapyCyclophosphamideCooperative StudyChildrenHuman Therapy EvaluationGene ExpressionCyclosporinesHuman SubjectKidney Function
Grant awards (9)
GENERAL CLINICAL RESEARCH CENTER$2,035,724
M01 · FY2008 · RR · contact PI
GENERAL CLINICAL RESEARCH CENTER$2,077,270
M01 · FY2007 · RR · contact PI
OPTIMAL TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS$388,400
U01 · FY2007 · DK · contact PI
GENERAL CLINICAL RESEARCH CENTER$2,139,310
M01 · FY2006 · RR · contact PI
OPTIMAL TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS$400,000
U01 · FY2006 · DK · contact PI
OPTIMAL TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS$271,217
U01 · FY2005 · DK
OPTIMAL TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS$289,912
U01 · FY2004 · DK
OPTIMAL TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS$596,003
U01 · FY2003 · DK
OPTIMAL TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS$175,229
U01 · FY2002 · DK